Related Experiment Videos
Randomized clinical trials in surgical oncology
1European Organization for Research and Treatment of Cancer, Brussels, Belgium.
Summary
Randomized clinical trials are standard for new drugs but less common for surgical oncology treatments. This paper argues for more pertinent surgical trials to establish treatment efficacy.
Area of Science:
- Surgical Oncology
- Clinical Trial Design
- Evidence-Based Medicine
Background:
- Randomized clinical trials (RCTs) are a cornerstone for approving new pharmaceutical therapies.
- The evaluation of new surgical techniques and adjuvant treatments often lacks rigorous RCTs.
- Existing trial models for anti-cancer drugs may not be suitable for surgical oncology.
Purpose of the Study:
- To highlight the necessity of conducting more randomized trials in surgical oncology.
- To discuss the challenges and propose solutions for more pertinent surgical trials.
- To advocate for robust evidence generation in the surgical treatment of cancer.
Main Methods:
- Review of current practices in clinical trial design for drugs versus surgical oncology.
- Discussion of the limitations of existing trial methodologies for surgical interventions.
- Exploration of potential adaptations for surgical oncology trials.
Main Results:
- A significant disparity exists in the number of RCTs published for new drugs compared to new surgical approaches.
- Current trial designs for anti-cancer drugs may not adequately assess the value of adjuvant surgical treatments.
- There is a need for tailored trial methodologies in surgical oncology.
Conclusions:
- Increased implementation of well-designed randomized clinical trials is crucial for advancing surgical oncology.
- Adapting trial designs to the unique nature of surgical interventions is essential for generating reliable evidence.
- More pertinent trials will improve the evaluation and adoption of novel treatments in surgical oncology.